Frontiers in Pharmacology | Drugs Outcomes Research and Policies

Systematic Review

Published on 10 Feb 2021

Prescription of Antibiotic Prophylaxis for Dental Implant Surgery in Healthy Patients: A Systematic Review of Survey-Based Studies

in Drugs Outcomes Research and Policies

Juan Carlos Bernabeu-Mira
Miguel Peñarrocha-Diago
David Peñarrocha-Oltra

Frontiers in Pharmacology

doi 10.3389/fphar.2020.588333

23,623 views
17 citations

Systematic Review

Published on 08 Feb 2021

Low Dose Rivaroxaban for Atherosclerotic Cardiovascular Diseases: A Systematic Review and Meta-analysis

in Drugs Outcomes Research and Policies

Can Chen
Yuanqing Kan
Zhenyu Shi
Daqiao Guo
Weiguo Fu
Yanli Li
Qianzhou Lv
Xiaoyu Li
Yi Si

Frontiers in Pharmacology

doi 10.3389/fphar.2020.608247

9,987 views
8 citations

Correction

Published on 08 Feb 2021

Corrigendum: Linking the Declarations of Helsinki and of Taipei: Critical Challenges of Future-Oriented Research Ethics

in Drugs Outcomes Research and Policies

Chieko Kurihara
Varvara Baroutsou
Sander Becker
Johan Brun
Brigitte Franke-Bray
Roberto Carlesi
Anthony Chan
Luis Francisco Collia
Peter Kleist
Luís Filipe Laranjeira

Frontiers in Pharmacology

doi 10.3389/fphar.2020.637775

1,722 views

Review

Published on 08 Feb 2021

Modalities and Mechanisms of Treatment for Coronavirus Disease 2019

in Drugs Outcomes Research and Policies

Zhihong Zuo
Ting Wu
Liangyu Pan
Chenzhe Zuo
Yingchuo Hu
Xuan Luo
Liping Jiang
Zanxian Xia
Xiaojuan Xiao
Jing Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2020.583914

8,656 views
9 citations

Original Research

Published on 08 Feb 2021

The Impact of Antimicrobial Stewardship Program on Injudicious Use of Cefuroxime

in Drugs Outcomes Research and Policies

Ann L. Arulappen
Monica Danial
Norliza Haron
Lim Choo Hau
Amer Hayat Khan

Frontiers in Pharmacology

doi 10.3389/fphar.2020.565818

3,010 views
3 citations

Original Research

Published on 05 Feb 2021

Several FDA-Approved Drugs Effectively Inhibit SARS-CoV-2 Infection in vitro

in Drugs Outcomes Research and Policies

Hua-Long Xiong
Jia-Li Cao
Chen-Guang Shen
Jian Ma
Xiao-Yang Qiao
Tian-Shu Shi
Sheng-Xiang Ge
Hui-Ming Ye
Jun Zhang
Quan Yuan

Frontiers in Pharmacology

doi 10.3389/fphar.2020.609592

7,367 views
31 citations

Original Research

Published on 05 Feb 2021

Impact of the Low-Price Medicine Policy on Medicine Supply in China: An Interrupted Time-Series Analysis

in Drugs Outcomes Research and Policies

Mingyue Zhao
Ali Hassan Gillani
Duan Ji
Zhitong Feng
Yu Fang
Caijun Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.621307

4,690 views
4 citations

Brief Research Report

Published on 05 Feb 2021

Graft Versus Host Disease Associated with Immune Checkpoint Inhibitors: A Pharmacovigilance Study and Systematic Literature Review

in Drugs Outcomes Research and Policies

Lee S. Nguyen
Lisa Raia
Bénédicte Lebrun-Vignes
Joe-Elie Salem

Frontiers in Pharmacology

doi 10.3389/fphar.2020.619649

7,440 views
7 citations

Original Research

Published on 05 Feb 2021

Hospitalization Expenditures and Out-Of-Pocket Expenses in Patients With Stroke in Northeast China, 2015–2017: A Pooled Cross-Sectional Study

in Drugs Outcomes Research and Policies

Zihua Ma
Gongman Deng
Zhaolin Meng
Huazhang Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2020.596183

4,809 views
15 citations

Original Research

Published on 05 Feb 2021

Drug Induced Liver Injury in Geriatric Patients Detected by a Two-Hospital Prospective Pharmacovigilance Program: A Comprehensive Analysis Using the Roussel Uclaf Causality Assessment Method

in Drugs Outcomes Research and Policies

Laura Pedraza
Olga Laosa
Leocadio Rodríguez-Mañas
Diego F Gutiérrez-Romero
Jesús Frías
José Antonio Carnicero
Elena Ramírez

Frontiers in Pharmacology

doi 10.3389/fphar.2020.600255

4,873 views
17 citations

Systematic Review

Published on 02 Feb 2021

Safety of Dabigatran as an Anticoagulant: A Systematic Review and Meta-Analysis

in Drugs Outcomes Research and Policies

Ya Zhou
Zhihao Yao
Linjie Zhu
Yong Tang
Jie Chen
Jianming Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2021.626063

6,190 views
11 citations

Original Research

Published on 02 Feb 2021

Prevalence and Predictors of Self-Medication Practice Among Teachers’ Education Training College Students in Amhara Region, Ethiopia: A Cross-Sectional Study

in Drugs Outcomes Research and Policies

Abebe Basazn Mekuria
Eshetie Melese Birru
Melkamu Teshome Tesfa
Mestayet Geta
Zemene Demelesh Kifle
Tsegaw Amare

Frontiers in Pharmacology

doi 10.3389/fphar.2020.593764

9,766 views
18 citations

Review

Published on 01 Feb 2021

Guidance for Demonstrating the Societal Value of new Antibiotics

in Drugs Outcomes Research and Policies

Steven Simoens
Isabel Spriet

Frontiers in Pharmacology

doi 10.3389/fphar.2020.618238

9,051 views
10 citations

Original Research

Published on 29 Jan 2021

Risk of Hospitalization Associated with Cardiovascular Medications in the Elderly Italian Population: A Nationwide Multicenter Study in Emergency Departments

in Drugs Outcomes Research and Policies

Giada Crescioli
Alessandra Bettiol
Roberto Bonaiuti
Marco Tuccori
Marco Rossi
Annalisa Capuano
Silvia Pagani
Giulia Spada
Mauro Venegoni
Giuseppe Danilo Vighi

Frontiers in Pharmacology

doi 10.3389/fphar.2020.611102

3,194 views
13 citations

Review

Published on 29 Jan 2021

HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons

in Drugs Outcomes Research and Policies

Andrey A. Poloznikov
Stepan A. Nersisyan
Dmitry M. Hushpulian
Eliot H. Kazakov
Alexander G. Tonevitsky
Sergey V. Kazakov
Valery I. Vechorko
Sergey V. Nikulin
Julia A. Makarova
Irina G. Gazaryan

Frontiers in Pharmacology

doi 10.3389/fphar.2020.621054

11,586 views
25 citations

Opinion

Published on 29 Jan 2021

What Is the Difference Between Observed Association and Causal Association, Signals and Evidence? Examples Related to COVID-19

in Drugs Outcomes Research and Policies

Vicki Osborne
Saad A. W. Shakir

Frontiers in Pharmacology

doi 10.3389/fphar.2020.569189

9,106 views
7 citations

Navigation group

Articles

Prescription of Antibiotic Prophylaxis for Dental Implant Surgery in Healthy Patients: A Systematic Review of Survey-Based Studies

Low Dose Rivaroxaban for Atherosclerotic Cardiovascular Diseases: A Systematic Review and Meta-analysis

Corrigendum: Linking the Declarations of Helsinki and of Taipei: Critical Challenges of Future-Oriented Research Ethics

Modalities and Mechanisms of Treatment for Coronavirus Disease 2019

The Impact of Antimicrobial Stewardship Program on Injudicious Use of Cefuroxime

Several FDA-Approved Drugs Effectively Inhibit SARS-CoV-2 Infection in vitro

Impact of the Low-Price Medicine Policy on Medicine Supply in China: An Interrupted Time-Series Analysis

Graft Versus Host Disease Associated with Immune Checkpoint Inhibitors: A Pharmacovigilance Study and Systematic Literature Review

Hospitalization Expenditures and Out-Of-Pocket Expenses in Patients With Stroke in Northeast China, 2015–2017: A Pooled Cross-Sectional Study

Drug Induced Liver Injury in Geriatric Patients Detected by a Two-Hospital Prospective Pharmacovigilance Program: A Comprehensive Analysis Using the Roussel Uclaf Causality Assessment Method

Safety of Dabigatran as an Anticoagulant: A Systematic Review and Meta-Analysis

Prevalence and Predictors of Self-Medication Practice Among Teachers’ Education Training College Students in Amhara Region, Ethiopia: A Cross-Sectional Study

Guidance for Demonstrating the Societal Value of new Antibiotics

Risk of Hospitalization Associated with Cardiovascular Medications in the Elderly Italian Population: A Nationwide Multicenter Study in Emergency Departments

HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons

What Is the Difference Between Observed Association and Causal Association, Signals and Evidence? Examples Related to COVID-19